Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome

N Engl J Med. 2000 Oct 5;343(14):1044-5. doi: 10.1056/NEJM200010053431412.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Amyloidosis / complications
  • Amyloidosis / diagnosis
  • Etanercept
  • Familial Mediterranean Fever / complications*
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Injections, Subcutaneous
  • Kidney Diseases / complications
  • Kidney Diseases / diagnosis
  • Nephrotic Syndrome / drug therapy*
  • Nephrotic Syndrome / etiology
  • Receptors, Tumor Necrosis Factor / genetics*
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Serum Amyloid P-Component
  • Tumor Necrosis Factor-alpha

Substances

  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Serum Amyloid P-Component
  • Tumor Necrosis Factor-alpha
  • Etanercept